^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Colon Cancer

Related cancers:
1d
U-TRANS: Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer (clinicaltrials.gov)
P=N/A, N=170, Recruiting, Gustave Roussy, Cancer Campus, Grand Paris | Not yet recruiting --> Recruiting | Trial completion date: Aug 2027 --> Mar 2028 | Trial primary completion date: Apr 2027 --> Sep 2027
Enrollment open • Trial completion date • Trial primary completion date
2d
Bundled Cancer Screening and Genetic Services Navigation (clinicaltrials.gov)
P=N/A, N=820, Recruiting, Georgetown University | Not yet recruiting --> Recruiting
Enrollment open
2d
New trial • Circulating tumor DNA
2d
Risk-reducing gynecologic surgery decisions in Lynch syndrome at a safety-net hospital and university medical center. (PubMed, Gynecol Oncol)
This exploratory analysis suggested a higher uptake of risk-reducing surgery at the safety-net hospital than at the university medical center. Understanding factors contributing to this difference will be critical to supporting gynecologic cancer risk management in Lynch syndrome.
Journal
|
MLH1 (MutL homolog 1) • MSH6 (MutS homolog 6) • MSH2 (MutS Homolog 2) • PMS2 (PMS1 protein homolog 2) • EPCAM (Epithelial cell adhesion molecule)
3d
The ubiquitin-like protein FAT10 enhances the autophagy-mediated degradation of ZO-1 by stabilizing ATG3 to promote the lung metastasis of colon cancer. (PubMed, Cell Oncol (Dordr))
Our findings demonstrate a novel pathway by which FAT10 activates autophagy by stabilizing ATG3, leading to ZO-1 degradation and promoting CC lung metastasis. This study provides new insights into the role of FAT10 in regulating protein homeostasis and offers a potential strategy for targeting the FAT10-ATG3-autophagy axis in the treatment of CC metastasis.
Journal
|
TJP1 (Tight Junction Protein 1) • ATG3 (Autophagy Related 3) • UBD (Ubiquitin D)
3d
A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer. (PubMed, Nat Cancer)
Analysis of CRC patient data revealed that the metastatic gene signature associated with the MAPK-high-WNT-low state correlated with poorer survival outcomes. These findings underscore the plasticity of metastasis-initiating cells in CRC driven by the opposing roles of MAPK and WNT signaling, despite their synergy observed during colon tumorigenesis.
Journal
|
KRAS (KRAS proto-oncogene GTPase)
|
KRAS mutation • KRAS G12D
3d
New trial
4d
Bioinspired Nanoplatform Potentiates Sonodynamic Immunotherapy by Remodeling the Antioxidant Tumor Microenvironment and Activating STING pathway. (PubMed, Theranostics)
Notably, it remodeled the tumor immune microenvironment by promoting CD8⁺ T cell infiltration, enhancing the secretion of IFN-γ and TNF-α, and reducing the populations of regulatory T cells and myeloid-derived suppressor cells. Mn3O4/QD@LM confirms the synergistic role of multi-enzyme activities and STING pathway activation in potentiating sonodynamic immunotherapy, and provides an innovative strategy to overcome TME-mediated therapy resistance.
Journal
|
CD8 (cluster of differentiation 8) • IFNG (Interferon, gamma) • TNFA (Tumor Necrosis Factor-Alpha) • CAT (Catalase)
4d
Comparison of Histopathologic Features of Right and Left Sided Colon Cancer. (PubMed, ANZ J Surg)
RCC was associated with a higher rate of dMMR and high-grade tumours, and a greater proportion of mucinous adenocarcinomas.
Journal
|
BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog) • RAS (Rat Sarcoma Virus)
|
BRAF V600E • MSI-H/dMMR • NRAS mutation • BRAF V600
4d
Germline haploinsufficiency of MUTYH causes mutational signature SBS18 in multiple tumour types and specifically raises colorectal cancer risk. (PubMed, NPJ Precis Oncol)
Mutational signatures in cancers can result in part from non-rare germline variation in DNA repair. The specific effect of MUTYH heterozygosity on CRC risk plausibly reflects the high baseline levels of oxidative damage and SBS18 activity in the colorectum.
Journal • Tumor mutational burden
|
TMB (Tumor Mutational Burden) • MBD4 (Methyl-CpG Binding Domain 4, DNA Glycosylase) • MUTYH (MutY homolog)
4d
Enrollment open